Bridgeway Capital Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.45M Sell
41,000
-1,300
-3% -$52.9K 0.03% 619
2025
Q4
$1.72M Sell
42,300
-4,000
-9% -$174K 0.04% 579
2025
Q3
$2.18M Buy
+46,300
New +$2.4M 0.05% 527
2021
Q1
Sell
-3,700
Closed -$414K 1365
2020
Q4
$414K Sell
3,700
-700
-16% -$66.3K 0.01% 1014
2020
Q3
$346K Hold
4,400
0.01% 1015
2020
Q2
$317K Sell
4,400
-1,600
-27% -$111K 0.01% 1023
2020
Q1
$344K Buy
+6,000
New +$553K 0.01% 879

Other funds holding CNMD

Bridgeway Capital Management's CNMD Position: Q1 2026 in Review

Bridgeway Capital Management reduced its CONMED (CNMD) stake by 3.1% in Q1 2026, selling an estimated $52.9K and leaving 41,000 shares worth $1.45M. The position accounts for 0.03% of the portfolio, ranked #619.

Bridgeway Capital Management first reported a position in CNMD in Q1 2020 and has held it in 7 quarters since. The position peaked at $2.18M in Q3 2025. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Bridgeway Capital Management held 41,000 shares of CONMED worth $1.45M as of Q1 2026.
  • Bridgeway Capital Management sold 1,300 CONMED shares in Q1 2026, an estimated $52.9K.
  • CONMED made up 0.03% of Bridgeway Capital Management's portfolio in Q1 2026, its #619 holding.
  • Bridgeway Capital Management first reported a position in CONMED in Q1 2020 and has held it in 7 quarters since.
  • Bridgeway Capital Management's CONMED position peaked at $2.18M in Q3 2025.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.